157 related articles for article (PubMed ID: 38295320)
21. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
[TBL] [Abstract][Full Text] [Related]
22. Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma.
Su Y; Wang L; Jiang C; Yue Z; Fan H; Hong H; Duan C; Jin M; Zhang D; Qiu L; Cheng X; Xu Z; Ma X
BMC Cancer; 2020 Feb; 20(1):102. PubMed ID: 32028911
[TBL] [Abstract][Full Text] [Related]
23. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
Zeng C; Stroup EK; Zhang Z; Chiu BC; Zhang W
Cancer Commun (Lond); 2019 Mar; 39(1):12. PubMed ID: 30922396
[TBL] [Abstract][Full Text] [Related]
24. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
[TBL] [Abstract][Full Text] [Related]
25. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF
BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123
[TBL] [Abstract][Full Text] [Related]
26. Genome-Wide Studies Reveal that H3K4me3 Modification in Bivalent Genes Is Dynamically Regulated during the Pluripotent Cell Cycle and Stabilized upon Differentiation.
Grandy RA; Whitfield TW; Wu H; Fitzgerald MP; VanOudenhove JJ; Zaidi SK; Montecino MA; Lian JB; van Wijnen AJ; Stein JL; Stein GS
Mol Cell Biol; 2016 Feb; 36(4):615-27. PubMed ID: 26644406
[TBL] [Abstract][Full Text] [Related]
27. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3.
Prickaerts P; Adriaens ME; Beucken TVD; Koch E; Dubois L; Dahlmans VEH; Gits C; Evelo CTA; Chan-Seng-Yue M; Wouters BG; Voncken JW
Epigenetics Chromatin; 2016; 9():46. PubMed ID: 27800026
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic Optical Mapping of 5-Hydroxymethylcytosine in Nanochannel Arrays.
Gabrieli T; Sharim H; Nifker G; Jeffet J; Shahal T; Arielly R; Levi-Sakin M; Hoch L; Arbib N; Michaeli Y; Ebenstein Y
ACS Nano; 2018 Jul; 12(7):7148-7158. PubMed ID: 29924591
[TBL] [Abstract][Full Text] [Related]
30. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
Yoo S; Bieda MC
BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
[TBL] [Abstract][Full Text] [Related]
31. MYCN and HIF-1 directly regulate
Hains AE; Uppal S; Cao JZ; Salwen HR; Applebaum MA; Cohn SL; Godley LA
Epigenetics; 2022 Dec; 17(13):2056-2074. PubMed ID: 35942521
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic Targeting of
Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
[TBL] [Abstract][Full Text] [Related]
33. 5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Saldanha G; Joshi K; Lawes K; Bamford M; Moosa F; Teo KW; Pringle JH
Mod Pathol; 2017 Jan; 30(1):60-68. PubMed ID: 27713424
[TBL] [Abstract][Full Text] [Related]
34. Bisulfite-Free, Nanoscale Analysis of 5-Hydroxymethylcytosine at Single Base Resolution.
Zeng H; He B; Xia B; Bai D; Lu X; Cai J; Chen L; Zhou A; Zhu C; Meng H; Gao Y; Guo H; He C; Dai Q; Yi C
J Am Chem Soc; 2018 Oct; 140(41):13190-13194. PubMed ID: 30278133
[TBL] [Abstract][Full Text] [Related]
35. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
[TBL] [Abstract][Full Text] [Related]
36. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
[TBL] [Abstract][Full Text] [Related]
37. Integrated detection of both 5-mC and 5-hmC by high-throughput tag sequencing technology highlights methylation reprogramming of bivalent genes during cellular differentiation.
Gao F; Xia Y; Wang J; Luo H; Gao Z; Han X; Zhang J; Huang X; Yao Y; Lu H; Yi N; Zhou B; Lin Z; Wen B; Zhang X; Yang H; Wang J
Epigenetics; 2013 Apr; 8(4):421-30. PubMed ID: 23502161
[TBL] [Abstract][Full Text] [Related]
38. High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma.
Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
J Exp Clin Cancer Res; 2014 Apr; 33(1):32. PubMed ID: 24716838
[TBL] [Abstract][Full Text] [Related]
39. Single base resolution analysis of 5-hydroxymethylcytosine in 188 human genes: implications for hepatic gene expression.
Ivanov M; Kals M; Lauschke V; Barragan I; Ewels P; Käller M; Axelsson T; Lehtiö J; Milani L; Ingelman-Sundberg M
Nucleic Acids Res; 2016 Aug; 44(14):6756-69. PubMed ID: 27131363
[TBL] [Abstract][Full Text] [Related]
40. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL
Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
